199 results on '"Hernandez-Alcoceba, Ruben"'
Search Results
2. Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome
3. High value of 64Cu as a tool to evaluate the restoration of physiological copper excretion after gene therapy in Wilson’s disease
4. Viral vector-mediated expression of [Na.sub.V]1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome
5. Broad virus inactivation using inorganic micro/nano-particulate materials
6. Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation
7. Gene therapies and COVID-19 vaccines: a necessary discussion in relation with viral vector-based approaches
8. Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment
9. Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation
10. Long-term metabolic correction of Wilson’s disease in a murine model by gene therapy
11. Application of a split‐Cre system for high‐capacity adenoviral vector amplification
12. Capsid-deficient alphaviruses generate propagative infectious microvesicles at the plasma membrane
13. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
14. Exogenous NaV1.1 activity in excitatory and inhibitory neurons reverts Dravet syndrome comorbidities when delivered post-symptom onset in mice with Dravet
15. Application of a split‐Cre system for high‐capacity adenoviral vector amplification.
16. Gene supplementation of CYP27A1 in the liver restores bile acid metabolism in a mouse model of cerebrotendinous xanthomatosis
17. Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations
18. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver
19. Identification of replication-competent HSV-1 Cgal + strain targets in a mouse model of human hepatocarcinoma xenograft
20. Target-Mediated Disposition Model Describing the Dynamics of IL12 and IFNγ after Administration of a Mifepristone-Inducible Adenoviral Vector for IL-12 Expression in Mice
21. Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis
22. Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence
23. Gene therapy of liver cancer
24. Evaluation of a new dual-specificity promoter for selective induction of apoptosis in breast cancer cells
25. Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B
26. Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer
27. Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice
28. High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy
29. Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors
30. Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses
31. Evaluation of hepatocellular carcinoma models for preclinical studies
32. Bektore biral terapeutiko baten efikazia eta toxizitateaten ebaluazioa Wilson gaixotasundun saguetan
33. Liver Expression of a MiniATP7B Gene Results in Long‐Term Restoration of Copper Homeostasis in a Wilson Disease Model in Mice
34. Inhibition of adenovirus infection by mifepristone
35. Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy
36. LUMO energy of model compounds of bispyridinium compounds as an index for the inhibition of choline kinase
37. Visualization of the therapeutic efficacy of a gene correction approach in Wilson’s disease by laser-ablation inductively coupled mass spectrometry
38. Abstract CT027: Oncolytic virus DNX-2401 with a short course of temozolomide for glioblastoma at first recurrence: Clinical data and prognostic biomarkers
39. Improvement of Adeno-Associated Virus-Mediated Liver Transduction Efficacy by Regional Administration in Macaca fascicularis
40. 164. Improvement of Gene Therapy for Wilson Disease
41. A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and Signaling
42. Cancer stem cell-associated microRNAs: searching for markers and targets in hepatocellular carcinoma
43. Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12
44. Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
45. Limitation of systemic exposure to transgenic interleukin-12 upon local treatment with armed oncolytic adenoviruses
46. 110. Safety and Antitumor Effect of Oncolytic and Helper-Dependent Adenoviruses Expressing Interleukin-12 Variants in a Hamster Pancreatic Cancer Model
47. Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors
48. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver
49. A Novel, Conditionally Replicative Adenovirus for the Treatment of Breast Cancer That Allows Controlled Replication of E1a-Deleted Adenoviral Vectors
50. Cytokines for the treatment of gastrointestinal cancers: clinical experience and new perspectives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.